Questex - Latest Emails, Sales & Deals| 11.08.24 | Novo, Lilly lost luster in Q3 market value recount; Daiichi teams up on subQ Enhertu planNovember 9, 2024 - 1 day ago| 11.08.24 | What medtech CEOs think of Trump’s tariffs; Allogene CAR-T prompts responses, 3 deaths in ph. 1November 9, 2024 - 1 day agoDoes your access & affordability strategy factor in the Patient-as-Payer?November 8, 2024 - 1 day ago| 11.08.24 | Allogene CAR-T tied to responses, 3 deaths in ph. 1; Nkarta shelves lymphoma programNovember 8, 2024 - 1 day ago| 11.08.24 | Biopharma braces for Trump's return; Kymera zeroes in on immunology; Novo GLP-1 delivers in MASH studyNovember 8, 2024 - 1 day ago| 11.08.24 | Pfizer taps Patrick Dempsey for cancer resources push; UK govt warns against ‘Instagram’ GLP-1 useNovember 8, 2024 - 1 day ago| 11.04.24 | Mucinex’s Mr. Mucus takes to Tinder to chat cold and flu; Savara sponsors talk show episode on aPAPNovember 8, 2024 - 2 days ago| 11.04.24 | Novo, Ascendis go after monthly GLP-1; Viking’s oral obesity med sees 6.8% weight lossNovember 8, 2024 - 2 days ago| 11.04.24 | Distalmotion grabs FDA de novo for Dexter robot; Boston Scientific bolsters PFA business with Cortex buyNovember 8, 2024 - 2 days ago| 11.07.24 | Gilead sees CAR-T sales slow, takes $1.75B impairment charge; Sarepta axes late-phase DMD drugNovember 7, 2024 - 2 days ago| 11.07.24 | Gilead’s CAR-T therapies, Moderna’s RSV vaccine fall short in Q3November 7, 2024 - 2 days agoNew GLP-1 Research, Linked Claims + EHR Database, ISPOR EU & MoreNovember 7, 2024 - 2 days ago| 11.07.24 | Sarepta stops late-stage DMD drug over safety sign; FDA slaps hold on Rapport nerve pain trialNovember 7, 2024 - 2 days ago| 11.07.24 | AGC’s new CEO looks to build ‘safe harbor’ for CDMO clients; Novavax pays $123.8M to settle UK COVID shot supply rowNovember 7, 2024 - 2 days agoDiscover the Future of Clinical Trials with Cell and Gene TherapiesNovember 7, 2024 - 2 days ago| 11.07.24 | Charles River revenue slides in Q3; Medidata crafts oncology, vaccine trial bundlesNovember 7, 2024 - 2 days agoThe One Cold Chain Handling ProcessNovember 7, 2024 - 2 days ago| 11.06.24 | Gilead-Arcellx Carvykti rival shows best-in-class potential; FDA revisits CAR-T boxed warnings for secondary cancersNovember 7, 2024 - 2 days agoAI Podcast: Transforming the Biopharmaceutical IndustryNovember 7, 2024 - 2 days agoSeq What You've Been Missing With InTraSeq™️ Single Cell AnalysisNovember 7, 2024 - 2 days ago| 11.06.24 | Novo drops $1.3B kidney drug after ph. 3 fail; Gilead, Arcellx build case for Carvykti rivalNovember 7, 2024 - 2 days ago| 11.06.24 | Biopharma digests a 2nd Trump term; An anatomy of the most successful drug launches in 2023November 7, 2024 - 2 days ago| 11.06.24 | FDA clears light-based therapy for dry AMD; CMS hands payments to renal denervation from Medtronic, RecorNovember 7, 2024 - 2 days agoThe Pharma Customer JourneyNovember 7, 2024 - 3 days ago| 11.06.24 | How pharma is bracing for Trump’s return; Novo ditches kidney drug, posts mixed GLP-1 salesNovember 7, 2024 - 3 days agoUnlock your field force potential with AI: Discover ZS FFE@Scale todayNovember 6, 2024 - 3 days ago| 11.06.24 | Moderna launches vaccine awareness push; Ogilvy Health taps Avalere alum as new chiefNovember 6, 2024 - 3 days agoWhat's New in ADME & DDINovember 6, 2024 - 4 days ago| 11.05.24 | Novo gets a handle on semaglutide supply rout; Nektar lines up $90M plant saleNovember 6, 2024 - 4 days agoCGMP oligonucleotide manufacturing and services for advanced therapiesNovember 6, 2024 - 4 days agoRevolutionize Contract Management for Value-Based Care SuccessNovember 6, 2024 - 4 days ago| 11.05.24 | Election spotlight: What's at stake for biopharma?; Amid Casgevy launch, Vertex preps another major rolloutNovember 6, 2024 - 4 days agoQuality Management Review Redefined: Driving Continuous Improvement in the Digital AgeNovember 6, 2024 - 4 days ago| 11.05.24 | AZ stock tanks amid China probe; Gilead-Arcellx, Sanofi tout successes in ASH data dropNovember 5, 2024 - 4 days ago| 11.05.24 | Beam hits hemoglobin goal in early gene editing data; Sana shifts away from cancer, CNS workNovember 5, 2024 - 4 days ago| 11.05.24 | Column Group biotech strikes pulmonary fibrosis pact; AI firm adopts Google Cloud for small molecule modelNovember 5, 2024 - 4 days ago| 11.04.24 | Election preview: What’s at stake for pharma?; Novo inks $285M deal to develop once-monthly GLP-1November 5, 2024 - 5 days ago| 11.04.24 | Incyte gets court to block rival JAK launch; Novartis defends radiopharma drugs with patent lawsuitsNovember 4, 2024 - 5 days agoJoin this week's webinar!November 4, 2024 - 5 days agoStay Ahead with the Latest in Clinical Trial InnovationNovember 4, 2024 - 5 days ago| 11.01.24 | Novo eyes MASH filings after semaglutide win; Distalmotion’s Dexter robot nabs de novo clearanceNovember 1, 2024 - 8 days ago| 11.01.24 | MASH clash: Novo readies filings as Madrigal's launch takes flight; FDA's Peter Marks revisits CAR-T safety labelsNovember 1, 2024 - 8 days ago| 11.01.24 | UCB Alzheimer's antibody fails ph. 2; Essa abandons sole clinical candidateNovember 1, 2024 - 8 days ago| 11.01.24 | The 2024 Biotech Graveyard; AZ's China president faces 'ongoing investigation' in the countryNovember 1, 2024 - 8 days ago| 11.01.24 | Eli Lilly, OAC create image gallery to fight obesity stigma; AstraZeneca’s latest Breztri ad cruises onto TV screensNovember 1, 2024 - 8 days ago| 10.29.24 | Poseida therapy edits liver gene in primates; 2 new drugs reduce parasite levels in animalsNovember 1, 2024 - 8 days agoLonza Launches the Early Advantage Program & Signs Multiple Early Stage CustomersNovember 1, 2024 - 8 days agoNew 2025 Lineup of Events for Pharma MarketersNovember 1, 2024 - 8 days ago| 10.29.24 | Novartis takes $800M hit on MorphoSys safety setback; Pfizer's RSV pipeline dries upNovember 1, 2024 - 9 days ago| 10.31.24 | The 2024 Biotech Graveyard; Madrigal's monster MASH launchOctober 31, 2024 - 9 days ago| 10.31.24 | Novo hit with FDA write-up at critical GLP-1 plant; Baxter bids adieu to Chinese IV fluids marketOctober 31, 2024 - 9 days agoUnlock faster, high-quality clinical research with AvacareOctober 31, 2024 - 9 days agoScale Your Drug Program with Bora’s Comprehensive CDMO SolutionsOctober 31, 2024 - 9 days ago| 10.31.24 | Bristol Myers CEO looks for 'further' cost savings; Teva hit with €463M antitrust fineOctober 31, 2024 - 9 days ago| 10.31.24 | 2024’s Biotech Graveyard; Amgen ghosts lung program after missing all endpointsOctober 31, 2024 - 9 days ago| 10.31.24 | Eli Lilly, Eisai under fire for Alzheimer’s trial conduct; Icon plots layoffs after disappointing Q3October 31, 2024 - 9 days ago2024 Executive Interviews at Fierce Biotech Summit and New Product PlanningOctober 31, 2024 - 9 days agoWatch: dPCR Academy on demandOctober 31, 2024 - 9 days ago| 10.30.24 | Lilly scraps lead candidate from $2.4B Dice roll; AbbVie, Biogen bump up full-year profit forecastsOctober 31, 2024 - 10 days ago| 10.30.24 | Major launches from Lilly, GSK disappoint; AZ's China president faces 'ongoing investigation'October 30, 2024 - 10 days ago| 10.30.24 | Valve under-expansion plagues Boston Scientific TAVR study; Abiomed clears pivotal trial for compressible pumpOctober 30, 2024 - 10 days ago| 10.30.24 | GSK, Lilly punt prospects picked up in $2B+ deals; Roche amends Alzheimer’s trial after patient deathOctober 30, 2024 - 10 days agoRevolutionize Contract Management for Value-Based Care SuccessOctober 30, 2024 - 10 days agoInnovating a Pharma Commercial Model for the FutureOctober 30, 2024 - 10 days agoStock up and save 15% on your next online orderOctober 30, 2024 - 10 days agoPartner with Cryoport Systems to take control of your ATMP supply chainOctober 30, 2024 - 10 days agoThe Fierce 50 Awards Gala is around the corner—reserve your seat now.October 30, 2024 - 10 days ago| 10.30.24 | J&J runs diverse new Tremfya psoriasis ad; Eli Lilly taps ‘public restroom rarity’ for UC campaignOctober 30, 2024 - 10 days ago| 10.29.24 | Novartis faces tough test in Scemblix’s new use; GSK inks $300M cash deal in lupusOctober 30, 2024 - 11 days agoThe Fierce 50 Awards Gala is around the corner—reserve your seat now.October 30, 2024 - 11 days ago| 10.29.24 | GSK plots major US expansion, 200 new jobs; Merck KGaA's MilliporeSigma pumps $76M into ADC plantOctober 29, 2024 - 11 days agoExpert Insights on Advancing Cell & Gene Therapy to MarketOctober 29, 2024 - 11 days ago| 10.28.24 | AbbVie pays $1.4B for Aliada, Alzheimer’s asset; Novartis tacks on $150M molecular glue dealOctober 28, 2024 - 12 days ago| 10.28.24 | Novartis, Apellis drop dueling datasets in rare kidney disease; Astellas pulls GA filing in EuropeOctober 28, 2024 - 12 days ago| 10.28.24 | At TCT, early TAVR studies pitch intervention as prevention; Medtronic collects approvals in TAVR, PFAOctober 28, 2024 - 12 days agoFireside Chat with the FDA: What's Beyond Cell & Gene TherapiesOctober 28, 2024 - 12 days agoJoin live: A Case Study on Automating Post-Procedure Follow UpOctober 28, 2024 - 12 days agoLeveraging Lab Data to Access Key Patient Insights and TrendsOctober 28, 2024 - 12 days ago| 10.28.24 | AZ, Daiichi back Black breast cancer patient campaign; Boston Scientific runs docuseries on male incontinenceOctober 28, 2024 - 12 days agoTransforming R&D: The Role of AIOctober 27, 2024 - 13 days ago, have you downloaded your copy yet?October 26, 2024 - 14 days ago| 10.25.24 | Septerna rides biotech IPO wave to $288M; End of GenSight's cash runway comes into viewOctober 26, 2024 - 14 days ago| 10.25.24 | Sanofi plays down Merck RSV threat; GSK plows $800M into PA expansionOctober 26, 2024 - 14 days ago| 10.25.24 | Sanofi thrives behind budding RSV blockbuster; Septerna’s upsized IPO more evidence of biotech investment rallyOctober 25, 2024 - 15 days agoSuper Early Bird Rate Ends TODAY for Fierce JPM Week 2025!October 25, 2024 - 15 days ago| 10.25.24 | Starboard aims to hold Pfizer 'accountable'; BioNTech-OncoC4 cancer trial under partial holdOctober 25, 2024 - 15 days ago| 10.25.24 | Senators probe Pfizer, Lilly DTC telehealth platforms; Incyte picks Dr. Pimple Popper for eczema campaignOctober 25, 2024 - 15 days ago| 10.24.24 | Europe’s slice of global trial pie shrinks; Revvity tool digitizes handwritten docsOctober 24, 2024 - 16 days ago| 10.24.24 | Eli Lilly, Eisai under fire for Alzheimer’s trial conduct; Troubled Marinus explores ‘strategic alternatives’October 24, 2024 - 16 days ago| 10.24.24 | Roche CEO joins chorus against Catalent buyout; Novo urges FDA to block GLP-1 compoundersOctober 24, 2024 - 16 days ago1...345678910111213141516171819202122232425262728293031LatestFind More Emails, Deals & Sales From These StoresWashington ExaminerTongalBody Butter BakeryGrove CollaborativeFeeling SwellHedonismSpace FurnitureCzarina KaftansRent It FurnishedBioSpaceRepp SportsBrioFlying Diamonds Of CaliforniaAllison Cole JewelryVRS DesignThe ChiveryQuality of Life SupplementsDiamond KineticsMJ BaleThe Beauty School